Company Profile
Dermata Therapeutics Stock Price, News & Analysis
- Ticker:
- DRMA
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Dermata Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
1.23 USD (0.00%)
Close
Last updated: June 23, 2026 at 00:00
4.95M USD
Market cap
Why the stock is moving
DRMA is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Dermata Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Dermata Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Dermata Therapeutics follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Dermata Therapeutics sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026
Source: Dermata Therapeutics
- 02
- 03
Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
Source: Dermata Therapeutics
- 04
A New Realm of Skincare is Coming: Dermata Teases New OTC Brand Identity
Source: Dermata Therapeutics
- 05
Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Source: Dermata Therapeutics
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Dermata Therapeutics (DRMA)?
Dermata Therapeutics (DRMA) most recently closed at 1.23 USD, a 0.00% move versus the previous session.
What is the market cap of Dermata Therapeutics (DRMA)?
Dermata Therapeutics currently has a market capitalization of 4.95M USD on BioPharmSignal.
What does Dermata Therapeutics do?
Dermata Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is DRMA stock listed?
Dermata Therapeutics (DRMA) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Dermata Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Dermata?
Dermata Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Dermata Therapeutics targeting with Dermata?
Dermata Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Therapeutics?
Dermata Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.